Cargando…
Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol
BACKGROUND: This paper reports on the availability of diagnostic tools and recommended anti-malarials in the 12-month period immediately following the implementation of a new national malaria treatment protocol (NMTP) in Papua New Guinea (PNG). Health worker adherence to the new NMTP is also examine...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222867/ https://www.ncbi.nlm.nih.gov/pubmed/24279720 http://dx.doi.org/10.1186/1475-2875-12-433 |
_version_ | 1782343121486479360 |
---|---|
author | Pulford, Justin Kurumop, Serah F Ura, Yangta Siba, Peter M Mueller, Ivo Hetzel, Manuel W |
author_facet | Pulford, Justin Kurumop, Serah F Ura, Yangta Siba, Peter M Mueller, Ivo Hetzel, Manuel W |
author_sort | Pulford, Justin |
collection | PubMed |
description | BACKGROUND: This paper reports on the availability of diagnostic tools and recommended anti-malarials in the 12-month period immediately following the implementation of a new national malaria treatment protocol (NMTP) in Papua New Guinea (PNG). Health worker adherence to the new NMTP is also examined and comparisons made with previously reported pre-implementation findings. METHODS: A countrywide cross-sectional survey in randomly selected primary health care facilities (n = 88). Data were collected via passive observation of the clinical case management of fever or suspected malaria patients and via an interviewer administered questionnaire completed with the officer in charge of each participating health care facility. RESULTS: Malaria rapid diagnostic tests (RDTs) and the new first-line anti-malarial medication, artemether-lumefantrine (AL), were available in 53.4% and 51.1% of surveyed heath facilities, respectively. However, they were more widely available in the larger health centres as compared to the smaller aid-posts (90.2% vs. 21.3% and 87.8% vs. 19.2%, respectively). Overall, 68.3% of observed fever cases (n = 445) were tested for malaria by RDT and 39% prescribed an anti-malarial, inclusive of 98.2% of RDT positive patients and 19.8% of RDT negative cases. The availability and use of malaria RDTs was greater in the current survey as compared to pre-implementation of the new NMTP (8.9% vs. 53.4% & 16.2% vs. 68.3%, respectively) as was the availability of AL (0% vs. 51.1%). The percentage of fever patients prescribed anti-malarials decreased substantially post implementation of the new NMTP (96.4% vs. 39.0%). CONCLUSIONS: PNG has achieved high coverage of malaria RDTs and AL at the health centre level, but these resources have yet to reach the majority of aid-posts. Malaria case management practice has substantially changed in the 12-month period immediately following the new NMTP, although full protocol adherence was rarely observed. |
format | Online Article Text |
id | pubmed-4222867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42228672014-11-07 Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol Pulford, Justin Kurumop, Serah F Ura, Yangta Siba, Peter M Mueller, Ivo Hetzel, Manuel W Malar J Research BACKGROUND: This paper reports on the availability of diagnostic tools and recommended anti-malarials in the 12-month period immediately following the implementation of a new national malaria treatment protocol (NMTP) in Papua New Guinea (PNG). Health worker adherence to the new NMTP is also examined and comparisons made with previously reported pre-implementation findings. METHODS: A countrywide cross-sectional survey in randomly selected primary health care facilities (n = 88). Data were collected via passive observation of the clinical case management of fever or suspected malaria patients and via an interviewer administered questionnaire completed with the officer in charge of each participating health care facility. RESULTS: Malaria rapid diagnostic tests (RDTs) and the new first-line anti-malarial medication, artemether-lumefantrine (AL), were available in 53.4% and 51.1% of surveyed heath facilities, respectively. However, they were more widely available in the larger health centres as compared to the smaller aid-posts (90.2% vs. 21.3% and 87.8% vs. 19.2%, respectively). Overall, 68.3% of observed fever cases (n = 445) were tested for malaria by RDT and 39% prescribed an anti-malarial, inclusive of 98.2% of RDT positive patients and 19.8% of RDT negative cases. The availability and use of malaria RDTs was greater in the current survey as compared to pre-implementation of the new NMTP (8.9% vs. 53.4% & 16.2% vs. 68.3%, respectively) as was the availability of AL (0% vs. 51.1%). The percentage of fever patients prescribed anti-malarials decreased substantially post implementation of the new NMTP (96.4% vs. 39.0%). CONCLUSIONS: PNG has achieved high coverage of malaria RDTs and AL at the health centre level, but these resources have yet to reach the majority of aid-posts. Malaria case management practice has substantially changed in the 12-month period immediately following the new NMTP, although full protocol adherence was rarely observed. BioMed Central 2013-11-27 /pmc/articles/PMC4222867/ /pubmed/24279720 http://dx.doi.org/10.1186/1475-2875-12-433 Text en Copyright © 2013 Pulford et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Pulford, Justin Kurumop, Serah F Ura, Yangta Siba, Peter M Mueller, Ivo Hetzel, Manuel W Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol |
title | Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol |
title_full | Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol |
title_fullStr | Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol |
title_full_unstemmed | Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol |
title_short | Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol |
title_sort | malaria case management in papua new guinea following the introduction of a revised treatment protocol |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222867/ https://www.ncbi.nlm.nih.gov/pubmed/24279720 http://dx.doi.org/10.1186/1475-2875-12-433 |
work_keys_str_mv | AT pulfordjustin malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol AT kurumopserahf malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol AT urayangta malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol AT sibapeterm malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol AT muellerivo malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol AT hetzelmanuelw malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol |